Vertical: CNMBase Year: 2025
Market Size (2025)
$49.62M
Projected (2032)
$67.02M
CAGR (2022–2032)
4.4%
Key Players
9+
Market Overview
The global monolaurin feed additive market was valued at USD 49.623 Million in 2025 and is projected to reach USD 67.023 Million by 2032, registering a CAGR of 4.39% during 2026–2032. The market expanded from USD 43.613 Million in 2022 to USD 47.534 Million in 2024, and is expected to add USD 17.400 Million in absolute terms between 2025 and 2032.
Monolaurin (glycerol monolaurate, GML) is the monoester of glycerol and lauric acid. In animal nutrition it is used as a functional, non-antibiotic additive that supports gut health and helps control Gram-positive bacteria and enveloped viruses in swine, poultry and other livestock. Demand is driven by the phase-out of antibiotic growth promoters in major livestock-producing countries, by persistent disease pressure such as African swine fever (ASF) and necrotic enteritis, and by the growth of commercial pork and poultry production. The market remains a specialised niche within the wider feed additives industry, which keeps the absolute value modest while supporting steady, mid-single-digit growth.
Key Findings
By livestock: Swine is the largest segment with USD 27.293 Million in 2025 (55.00% share), while Others is the fastest-growing segment at a CAGR of 5.59%. Poultry, the second-largest segment, is projected to grow at 4.91%.
By physical form: Powder dominates with USD 42.180 Million in 2025 (85.00% share). Others is the fastest-growing form at a CAGR of 5.84%.
By region: Asia Pacific is the leading region with USD 15.879 Million in 2025 (32.00% share). Middle East & Africa is the fastest-growing region at a CAGR of 5.20%, followed by Asia Pacific at 5.09%.
By country: The U.S. is the leading country market with USD 8.515 Million in 2025, closely followed by China at USD 8.257 Million. India is the fastest-growing country at a CAGR of 8.70%, rising from USD 1.429 Million in 2025 to USD 2.574 Million in 2032.
Segmentation Summary
The market is analysed by livestock (Swine, Poultry and Others), by physical form (Powder and Others) and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level analysis within each region. Swine accounted for USD 27.293 Million in 2025 and is expected to reach USD 35.455 Million by 2032, reflecting the long-established use of medium-chain fatty acid derivatives in piglet and sow diets. Poultry, valued at USD 17.368 Million in 2025, is set to reach USD 24.303 Million by 2032 as broiler integrators replace in-feed antibiotics with gut-health programmes. Others, covering species beyond swine and poultry, is the smallest but fastest-growing livestock segment.
Powder is the dominant physical form because it is easily blended into premixes and compound feed and is stable through storage. The Others form segment, valued at USD 7.443 Million in 2025, is expected to reach USD 11.086 Million by 2032, supported by liquid and drinking-water formats and carrier-based or protected products.
Competitive Landscape Summary
The market is moderately fragmented. Adisseo, through the FRA C12 range acquired with the FRAmelco Group, holds a leading position in lauric acid glycerides for feed. Oleochemical producers such as Oleon (Avril Group) and Wilmar International supply high-purity glycerol monolaurate, while Eastman, BASF and Anitox compete with monoglyceride-based gut-health products in the same applications. A group of specialist suppliers, including Proviron and Chinese producers such as Hangzhou De Mark Industrial and Hubei Horwath Biotechnology, serves price-sensitive and regional demand. Competition centres on product purity (alpha-monoglyceride content), trial evidence, technical service and access to premix and integrator customers.
Challenges and Opportunities
The main challenges are the price volatility of lauric oils (coconut and palm kernel oil), which are the source of lauric acid; competition from alternative gut-health additives such as organic acids, free medium-chain fatty acid blends, probiotics and phytogenics; and variable field results that make return on investment harder to demonstrate. In the European Union, glycerol monolaurate is generally marketed as a feed material rather than as an authorised feed additive, which limits the functional claims suppliers can make.
Opportunities arise from feed biosecurity programmes aimed at ASF and other viral threats, from rapid poultry sector growth in India, Southeast Asia, the Middle East and Africa, and from new delivery formats such as drinking-water solutions and synergistic blends with organic acids.
Future Outlook
Between 2025 and 2032 the market is expected to grow from USD 49.623 Million to USD 67.023 Million. Asia Pacific will contribute the largest absolute increase (USD 6.600 Million), followed by Europe (USD 3.934 Million) and North America (USD 3.265 Million). Poultry and the Others form segment are expected to gain share steadily, while swine and powder will remain the largest segments throughout the forecast period. Suppliers that combine reliable high-purity product, published efficacy data and strong technical service are best placed to capture this growth.
The Monolaurin Feed Additive Market market is projected to grow at a CAGR of 4.4% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Monolaurin, also known as glycerol monolaurate (GML), glyceryl laurate or 1-lauroyl-glycerol (CAS No. 142-18-7), is a monoglyceride formed by the esterification of glycerol with lauric acid (C12:0), a medium-chain saturated fatty acid. Commercially, it is produced by direct esterification of glycerol and lauric acid or by glycerolysis of lauric oils such as coconut oil and palm kernel oil, followed in high-purity grades by molecular distillation to raise the alpha-monoester content.
In animal nutrition, monolaurin is used as a functional feed ingredient. Because the molecule is amphiphilic, it disrupts the lipid membranes of Gram-positive bacteria (such as Clostridium perfringens and Streptococcus spp.) and of enveloped viruses. It is less dependent on gut pH than free fatty acids and remains active at low inclusion rates. It is used to support intestinal health, help reduce reliance on antibiotics, and act as a feed mitigant against pathogens carried in feed.
Included in the scope:
Feed-grade monolaurin / glycerol monolaurate products of different purity levels, supplied as powder or in other physical forms (for example liquid, drinking-water, granulated or carrier-based products).
Products in which monolaurin is the principal active component, sold to premix manufacturers, compound feed producers, integrators and farms.
Use in swine, poultry and other livestock species.
Excluded from the scope:
Food-, cosmetic- and pharmaceutical-grade monolaurin and dietary supplements for human use.
Free lauric acid, coconut oil and other lauric fats sold as energy sources, and other monoglycerides (such as monobutyrin or monocaprin) sold as stand-alone products.
The value of compound feed or premixes in which monolaurin is incorporated; only the value of the monolaurin additive is counted.
Scope of the Study
The study covers the global monolaurin feed additive market and provides historic data for 2022–2024, base-year estimates for 2025 and forecasts for 2026–2032. All values are presented in USD Million, and growth rates are stated as CAGR for 2026–2032.
Research Objectives
To estimate and forecast the size of the global monolaurin feed additive market in value terms (USD Million) for 2022–2032.
To analyse the market by livestock (Swine, Poultry, Others) and by physical form (Powder, Others), and to identify the largest and fastest-growing segments.
To assess regional and country-level demand for monolaurin feed additives across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To evaluate the effect of antibiotic growth promoter restrictions and antimicrobial reduction policies on demand for monolaurin.
To examine the role of monolaurin in feed biosecurity and disease management, including African swine fever and enteric bacterial diseases.
To analyse the supply chain from lauric oil feedstocks to end users, and the effect of raw material price volatility on the market.
To profile the competitive environment, including the positioning of leading suppliers and key developments since 2022.
To identify opportunities, trends and challenges that will shape the market through 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured research process combining secondary research, primary research, market size estimation and forecasting. The process began with defining the market and its segmentation, followed by collection of data on livestock populations, feed production, additive usage patterns, pricing and supplier activity. These inputs were used to build market models that were then validated with industry participants and cross-checked through data triangulation.
Market definition and scoping: product definition, inclusions and exclusions, and segmentation framework.
Secondary research: collection of data from public and paid sources on livestock production, feed output, regulation and supplier activity.
Primary research: discussions with supply-side and demand-side participants to validate assumptions, pricing and adoption rates.
Market modelling: estimation of market size through top-down and bottom-up approaches.
Validation and triangulation: reconciliation of estimates from different approaches and sources.
Forecasting and reporting: projection of market values for 2026–2032 and analysis of the findings.
Secondary Research
Secondary research established the baseline for market sizing and provided context on demand drivers, regulation and competition. The main source types were:
Industry associations: feed manufacturer and feed additive associations, such as the International Feed Industry Federation (IFIF), FEFAC in Europe, the American Feed Industry Association (AFIA) and national feed and poultry associations.
Government and regulatory bodies: the U.S. Department of Agriculture (USDA), the U.S. Food and Drug Administration Center for Veterinary Medicine, the European Food Safety Authority (EFSA), the European Commission, China's Ministry of Agriculture and Rural Affairs (MARA), India's Department of Animal Husbandry and Dairying and Brazil's Ministry of Agriculture and Livestock (MAPA).
Intergovernmental organisations: the Food and Agriculture Organization (FAOSTAT), the World Organisation for Animal Health (WOAH) and the OECD-FAO Agricultural Outlook, for livestock production, antimicrobial use and disease data.
Company sources: annual reports, investor presentations, product literature and press releases of feed additive and oleochemical companies.
Trade journals and scientific literature: animal nutrition and feed industry publications, and peer-reviewed studies on monoglycerides and medium-chain fatty acids in animal diets.
Paid databases: trade statistics, company financial databases and commodity price databases for lauric oils and glycerol.
Primary Research
Primary research was used to validate secondary findings, fill data gaps and obtain qualitative insight into adoption patterns, pricing and competitive dynamics. Interviews were conducted through telephone and online discussions using structured questionnaires.
Supply-side respondents: product managers, sales and technical managers at monolaurin and monoglyceride producers, oleochemical companies, feed additive distributors and premix manufacturers.
Demand-side respondents: nutritionists at compound feed mills and integrated swine and poultry producers, veterinarians, farm managers and procurement specialists.
Objectives: to validate market size and segment splits, understand inclusion rates and pricing, assess the impact of regulation and disease pressure, and identify emerging products and competitive strategies.
Market Size Estimation
Bottom-up approach: Country-level demand was estimated from livestock populations and feed production by species, the share of feed using monolaurin, typical inclusion rates and average selling prices. Country values were aggregated to regional and global totals.
Top-down approach: The global feed additives and gut-health additives markets were used as the starting point. The share attributable to monolaurin was derived from supplier revenue analysis, product portfolio mapping and expert input, and then allocated to regions, countries and segments.
Data triangulation: Results from the bottom-up and top-down approaches were compared and reconciled with supplier-side estimates and primary interview inputs. Where differences arose, assumptions were reviewed until the estimates converged within an acceptable range.
Forecasting Methodology
Forecasts for 2026–2032 were developed using a combination of historic trend analysis, driver-based modelling and expert validation. The main factors considered were:
Projected growth in pork, poultry and other livestock production by country.
Regulatory developments on antibiotic use in feed and their adoption timelines.
Disease pressure, including African swine fever, avian influenza and enteric diseases, and the uptake of feed biosecurity measures.
Price trends of lauric oils, lauric acid and glycerol, and their effect on product pricing.
Adoption of competing gut-health additives and new delivery formats.
Macroeconomic conditions, feed cost trends and livestock producer margins.
Assumptions and Limitations
Market values are in nominal USD; exchange rates are assumed to be stable over the forecast period.
No major new regulatory restriction on the use of glycerol monolaurate in feed is assumed in the key markets during the forecast period.
Livestock production follows the trends indicated by government and intergovernmental outlooks, with no extreme disruptions beyond current disease patterns.
Company-level revenues from monolaurin are generally not disclosed separately; supplier-side estimates are therefore based on portfolio analysis and industry input.
Products combining monolaurin with other monoglycerides or fatty acids are assigned to the market only where monolaurin is the principal active component, which involves a degree of judgement.
Rest-of-region values aggregate several smaller countries where individual data are limited.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The monolaurin feed additive market is moderately fragmented. A small number of established specialty and oleochemical companies supply branded, high-purity products backed by trial data, while a larger group of regional producers, particularly in China, supply lower-cost grades. In addition, several large feed additive and chemical companies offer monoglyceride-based gut-health products that compete with monolaurin in the same swine and poultry applications.
Competition is based on product purity and consistency, published efficacy data, technical service, regulatory compliance and price. Access to lauric acid feedstock is an advantage for integrated oleochemical producers, while specialty additive companies compete through formulation know-how and strong relationships with nutritionists, premix manufacturers and integrators. Acquisitions by larger groups, such as Adisseo's acquisition of the FRAmelco Group, have increased the reach of specialist glyceride products.
Key Player Positioning
Leaders: Adisseo is the leading company in lauric acid glycerides for feed, through the FRA C12 and FRA C12 Dry products obtained with the acquisition of the FRAmelco Group. Bluestar Adisseo reported revenue of RMB 17.231 billion for FY2025. Its global sales network, production sites and research programme on glycerides, including vaccination-compatibility studies, support its position.
Challengers: Oleon, the oleochemical business of France's Avril Group, supplies glycerol monolaurate for feed under its Radiamuls MG range and is investing in technical marketing for poultry and swine. Eastman (FY2025 revenue USD 8.752 billion) competes with its Entero-Nova monoglyceride range and Protaq Bond for drinking water, built on the 3F Feed & Food business acquired in 2021. BASF (2025 sales EUR 59.7 billion) offers BalanGut LS, a short- and medium-chain glyceride product for pigs and poultry, supported by its global animal nutrition network.
Niche and specialist players: Wilmar International (FY2024 revenue USD 67.4 billion) is a large lauric oil and oleochemical producer that supplies Wilfaester MONO-C12 monolaurin, giving it an upstream cost position although feed is a small part of its business. Proviron, a privately held Belgian company, produces alpha-monoglycerides, including monolaurin, for feed. Anitox, part of Iluma Alliance since July 2024, entered the segment with its AvrX Prime monoglyceride blend in 2026. Chinese producers such as Hangzhou De Mark Industrial (Haurin 600) and Hubei Horwath Biotechnology (OmniGuard GL900) supply monolaurin products mainly to price-sensitive and regional markets; their revenues are not publicly disclosed.
Threat of New Entrants: Medium
Basic production technology for monoglycerides is well known, and several Chinese and Southeast Asian producers have entered with lower-cost products.
Barriers include access to lauric feedstocks, distillation capacity for high-purity grades, quality certifications such as GMP+ and the need for efficacy trial data.
Established relationships between leading suppliers and integrators make it difficult for new entrants to win large accounts.
Bargaining Power of Suppliers: Medium
Lauric oil supply is concentrated in a few countries, and prices are volatile.
Large integrated oleochemical companies supply both raw materials and finished monolaurin, which strengthens their position.
Glycerol is widely available from biodiesel and oleochemical production, which limits supplier power for this input.
Bargaining Power of Buyers: High
Large integrators, feed mills and premix companies buy in volume and negotiate on price.
Buyers can choose from many alternative gut-health additives and can switch suppliers with limited cost.
Buyers increasingly require trial data and technical support before adopting a product.
Threat of Substitutes: High
Organic acids, free medium-chain fatty acids, other monoglycerides, probiotics, phytogenics and enzymes all target similar outcomes.
In the European Union, the end of therapeutic zinc oxide use in piglet feed from June 2022 increased demand for all alternatives, not only monolaurin.
Intensity of Competitive Rivalry: Medium
The market includes a few established specialty suppliers and a larger number of regional producers, with competition on purity, price and service.
The market is growing steadily, which reduces direct price competition among leading suppliers.
Differentiation through formulations, trial data and brand reputation limits pure price-based rivalry.
Threat of New Entrants: Medium; Accessible technology, but purity, certification and trial data create barriers.
Bargaining Power of Suppliers: Medium; Concentrated lauric oil supply offset by wide glycerol availability.
Bargaining Power of Buyers: High; Large, price-sensitive buyers with many alternatives.
Threat of Substitutes: High; Wide range of non-antibiotic gut-health additives.
Intensity of Competitive Rivalry: Medium; Moderately fragmented market with differentiation on quality and service.
Market estimates by geography (2032)
InsightAsia Pacific leads with $22.48M by 2032, while Middle East & Africa is projected to grow fastest at a 5.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $9.73M | $11.77M | $14.18M | 3.8% | 21% |
| Europe | $12.43M | $14.93M | $17.83M | 3.7% | 27% |
| Asia Pacific | $13.71M | $17.54M | $22.48M | 5.1% | 34% |
| Latin America | $5.60M | $7.10M | $8.99M | 4.8% | 13% |
| Middle East & Africa | $2.14M | $2.75M | $3.54M | 5.2% | 5% |
| Total | $43.61M | $54.08M | $67.02M | 4.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$67.02M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Swine | $35.46M | 3.8% | 53% |
| Poultry | $24.30M | 4.9% | 36% |
| Others | $7.27M | 5.6% | 11% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Monolaurin Feed Additive Market covering market dynamics, competitive landscape, and strategic outlook.
The Monolaurin Feed Additive Market market is projected to reach $67.02M by 2032, growing at 4.4% CAGR. The Swine segment holds the largest share.
The monolaurin feed additive market is shaped by regulation on antibiotic use, disease pressure in livestock, growth in animal protein demand and the economics of lauric oil feedstocks. This chapter assesses the drivers, restraints, opportunities, trends and challenges. The growth factor analysis in Section 4.2 rates five macro and five micro factors by impact type and by an impact score out of 10 for 2026–2027, 2028–2030 and 2031–2032; these scores are analyst assessments based on the research conducted for this study.
Restrictions on Antibiotic Growth Promoters
Regulatory action against the use of antibiotics for growth promotion is the most important driver of the market. In the European Union, Regulation (EC) No 1831/2003 ended the authorisation of antibiotics as feed additives from 1 January 2006, and Regulation (EU) 2019/6 on veterinary medicinal products, applicable since 28 January 2022, prohibits antimicrobials for growth promotion and restricts their routine preventive use. China's Ministry of Agriculture and Rural Affairs, through Announcement No. 194 (2019), withdrew growth-promoting drug feed additives from 1 January 2020. In the United States, medically important antimicrobials in feed have required veterinary oversight under the Veterinary Feed Directive since 2017, and the FDA completed the transition of the remaining over-the-counter medically important antimicrobials to prescription status in June 2023. Brazil banned several antimicrobials as performance enhancers in January 2020. According to WOAH, 71% of reporting countries no longer use antimicrobials for growth promotion, while 22% still do, which points to further policy-driven demand. These measures push producers towards non-antibiotic tools such as monolaurin to manage gut health and performance.
African Swine Fever and Feed Biosecurity
African swine fever remains a major threat to the global pig industry. WOAH data show that between January 2022 and April 2026, 85 countries were affected, with 14,414 outbreaks in domestic pigs and more than 2.57 million domestic pigs lost. Because ASF virus can survive in feed ingredients, producers and feed mills increasingly use feed mitigants as part of biosecurity programmes. Published research (Jackman et al., Journal of Animal Science and Biotechnology, 2020) found that glycerol monolaurate was more potent than free medium-chain fatty acids and inactivated ASF virus in feed, with reductions of up to 99.8%. Monolaurin is also active against other enveloped viruses relevant to swine. This positions the product within feed safety budgets as well as nutrition budgets, broadening its use in swine-producing countries such as China, Vietnam, the Philippines and Germany, where ASF has affected domestic or wild pig populations.
Growth in Animal Protein Production
Rising consumption of animal protein expands the livestock base on which monolaurin is used. The OECD-FAO Agricultural Outlook 2025–2034 projects global meat output to increase by about 13% by 2034, with poultry consumption rising by about 21% and pig meat by about 5%. USDA Foreign Agricultural Service estimates put global pork production at about 119.5 million tonnes in 2025, with a forecast of about 120.2 million tonnes in 2026, led by China. Growth is concentrated in Asia, Latin America and Africa, where production is shifting from backyard systems to commercial integrated operations that use formulated feed and premixes. As integration increases, so does the use of specialty additives, including monolaurin, to manage disease risk in high-density production. This trend underpins the higher growth rates of the poultry segment and of the Asia Pacific, Latin America and Middle East & Africa regions in this market.
Growing Scientific Evidence on Gut Health Benefits
A growing body of research supports the use of monolaurin in swine and poultry diets. Glycerol monolaurate has a much lower critical micelle concentration than free lauric acid, which allows it to act at lower doses. Trials in broilers have reported reduced mortality from necrotic enteritis when 1-monoglycerides were added to starter diets, and studies in sows have found that alpha-monolaurin supplementation in late gestation and lactation raised milk immunoglobulin levels and piglet weaning weights. Large commercial broiler trials with medium-chain monoglycerides have reported higher body weight and lower mortality. Suppliers also publish data on compatibility with vaccination programmes; for example, Adisseo reported in 2025 that FRA C12 Dry at 3 kg/t did not reduce infectious bronchitis vaccine efficacy in broilers. This evidence helps nutritionists justify inclusion and supports wider adoption.
Feed Mitigation Programmes for Viral Threats
The continued spread of ASF, together with the risk of other viral diseases entering through feed supply chains, creates an opportunity for monolaurin to be positioned as a feed mitigant. Feed mills and integrators that import ingredients from regions with disease outbreaks can include monolaurin in biosecurity protocols, which opens a budget line separate from performance additives. Suppliers that generate challenge-trial data and work with veterinarians and feed safety teams can build long-term contracts in this application.
Expansion in High-Growth Poultry Markets
Poultry production is growing quickly in India, Southeast Asia, the Middle East and Africa. India is the fastest-growing country in this market at a CAGR of 8.70%, with poultry accounting for 78.00% of Indian demand in 2025. Saudi Arabia and the UAE, where poultry represents most of the market, are expanding domestic production to improve food security. Integrators in these countries are adopting structured gut-health programmes as they scale up, creating demand for monolaurin in broiler and layer diets.
New Formats and Synergistic Blends
The Others physical form segment, which includes liquid and other non-powder formats, is the fastest-growing form at a CAGR of 5.84%. Drinking-water applications allow targeted use during high-risk periods such as weaning, placement of chicks or vaccination. There is also scope for blends that combine monolaurin with organic acids, other monoglycerides or botanicals to broaden the spectrum of activity. Suppliers that offer these formats and blends can differentiate from commodity powder products.
Volatility of Lauric Oil Feedstock Prices
Lauric acid is derived mainly from coconut oil and palm kernel oil, whose supply is concentrated in the Philippines, Indonesia and Malaysia. Prices are affected by weather, crop cycles and demand from food and oleochemical uses. Coconut Community data show that coconut oil prices rose from about USD 1,976 per tonne in January 2025 to a peak of about USD 2,742 per tonne in August 2025, before easing to about USD 2,285 per tonne in December 2025. Such swings raise production costs for monolaurin manufacturers, compress margins and make price-sensitive feed producers more likely to switch to cheaper alternatives.
Competition from Alternative Gut-Health Additives
Monolaurin competes with a wide range of non-antibiotic additives, including organic acids, free medium-chain fatty acid blends, butyrate and other monoglycerides, probiotics, prebiotics, phytogenics and enzymes. Many of these products target the same gut-health and pathogen-control outcomes and are supported by large suppliers with broad portfolios. Results can vary by challenge model; for example, one study found that a lauric monoglyceride product at 0.3% did not significantly inhibit porcine epidemic diarrhoea virus in feed, while a C6–C10 fatty acid blend did. This makes it harder for monolaurin to secure a fixed place in feed formulations.
Regulatory Classification Constraints
In the European Union, glycerol monolaurate is generally placed on the market as a feed material under the Catalogue of feed materials (Regulation (EU) No 68/2013), rather than as an authorised zootechnical feed additive. As a result, suppliers cannot make antimicrobial or performance claims of the type allowed for authorised additives, which limits marketing and can slow adoption among risk-averse buyers.
Shift Towards High-Purity Alpha-Monoglycerides
Buyers are paying more attention to the alpha-monoglyceride content of products, because this determines antimicrobial activity. Suppliers increasingly offer distilled grades with high monolaurin content and specify purity on product data sheets. Lower-purity products remain in use in price-sensitive markets, which creates a two-tier market.
Consolidation through Acquisitions
Larger feed additive companies are acquiring specialist suppliers to build specialty portfolios. Adisseo acquired the FRAmelco Group, a specialist in short- and medium-chain glycerides, and completed the acquisition of Nor-Feed in February 2023; Anitox was acquired by Iluma Alliance in July 2024. Consolidation gives specialist products wider distribution but also raises competitive pressure on independent producers.
Combination of Monoglycerides with Other Additives
Suppliers are developing programmes that combine monoglycerides of different chain lengths with organic acids, as illustrated by Eastman's Entero-Nova range and Anitox's AvrX Prime launch in July 2026. This trend increases competition for pure monolaurin products but also expands overall use of monoglyceride technology in feed.
Demonstrating Return on Investment
A key challenge is demonstrating consistent returns under field conditions, where results depend on disease pressure, diet composition and management. Producers increasingly expect suppliers to provide on-farm trial support and cost-benefit analysis before adopting the product at scale.
The monolaurin feed additive value chain links tropical oil production with livestock farming. The main stages are described below.
Monolaurin is regulated differently across regions, either as a feed material, as a generally recognised safe substance or within feed additive catalogues. Antibiotic reduction policies are also highly relevant because they shape demand for alternatives.
February 2023: Adisseo; Acquisition; Completed the acquisition of Nor-Feed, a French producer of botanical feed ingredients, expanding its specialty additives portfolio alongside the FRA glyceride range.
December 2023: Oleon; Technical publication; Published technical content on its glycerol monolaurate feed grades, presenting broiler performance and gut health benefits.
July 2024: Eastman; Research; Published broiler colibacillosis trial results showing that its monoglyceride programme achieved feed conversion comparable to a bacitracin control.
July 2024: Anitox; Acquisition; Anitox was acquired by Iluma Alliance, extending the reach of its feed safety and gut-health portfolio.
November 2024: Oleon; Exhibition; Showcased its feed glyceride portfolio, including glycerol monolaurate, at EuroTier 2024 in Hanover, Germany.
October 2025: Adisseo; Research; Published data showing that FRA C12 Dry at 3 kg/t did not reduce infectious bronchitis vaccine efficacy in broilers.
July 2026: Anitox; Product launch; Launched AvrX Prime, a blend of short- and medium-chain monoglycerides for early-stage broiler nutrition, at the World's Poultry Congress in Toronto, Canada.
September 2026: Proviron; Exhibition; Presented its monoglyceride feed technology at SPACE 2026 in Rennes, France.
Political
Government action plans on antimicrobial resistance, such as the EU One Health approach and national action plans in China, the U.S., Brazil and India, favour non-antibiotic additives.
Food security policies in the Middle East, Africa and Asia support expansion of domestic poultry and pork production.
Trade measures linked to animal disease outbreaks affect livestock production and feed ingredient flows.
Economic
Volatile coconut and palm kernel oil prices directly affect production costs.
Feed costs and livestock producer margins determine willingness to pay for specialty additives.
Growth of integrated commercial livestock production in emerging economies increases the addressable market.
Social
Consumer demand for meat produced with reduced or no antibiotics encourages producers to adopt alternatives.
Rising incomes and urbanisation increase demand for pork and poultry in Asia, Africa and Latin America.
Religious dietary practices limit pork consumption in parts of the Middle East and Asia, shaping the livestock mix.
Technological
Molecular distillation enables high-purity monolaurin with greater antimicrobial activity.
Encapsulation, carrier and liquid formulations broaden application options, including drinking water.
Research on synergy between monoglycerides and organic acids supports new blended products.
Environmental
Sourcing of palm kernel oil raises deforestation concerns, increasing demand for RSPO-certified supply.
Reduced antibiotic use lowers the release of antimicrobial residues into the environment.
Climate effects on coconut and palm yields can affect raw material availability.
Legal
Classification of monolaurin as a feed material in the EU limits the claims suppliers can make.
Feed safety rules such as the EU feed hygiene regulation and the U.S. FSMA require documented quality systems.
Bans on growth-promoting antibiotics in the EU, China, Brazil and other countries create a legal basis for alternative demand.
Profiles of 30 companies operating in the Monolaurin Feed Additive Market market, including revenue, employee count, and market positioning where available.
Showing 30 of 30 companies
### Identity and listing | Field | Detail | |---|---| | Entity profiled | Eastman Chemical Company (exact legal-name match; active; publicly listed) | | Listing status vs. input list | Confirmed public company — matches the type supplied | | Former names / predecessors | Tennessee Eastman Company / Corporation (Kodak's chemical subsidiary, founded 1920); Eastman Chemical Products (marketing arm); operated as Eastman Kodak's chemicals division until spin-off | | Founding year | 1920 (Kingsport, Tennessee, by George Eastman) | | Incorporation | Delaware, 1993 (2026 Proxy, "Eastman at a Glance") | | Spin-off from Eastman Kodak | Effective 31 Dec 1993; NYSE trading from early January 1994 | | Headquarters | 200 South Wilcox Drive, Kingsport, Tennessee 37660, USA | | Exchange / ticker | New York Stock Exchange: EMN | | ISIN / CUSIP | US2774321002 / 277432100 (standard identifiers; not re-checked against filing cover page) | | Fiscal year end | 31 December | | Auditor | PricewaterhouseCoopers LLP (ratified for FY2026 at 7 May 2026 AGM; lead partner rotated in 2026) | | Website | www.eastman.com | | Market capitalization | USD 7.39 billion (5 Oct 2026, share price USD 64.62; 114.33 million shares) | | Enterprise value | USD 12.16 billion (S&P Global via StockAnalysis, 5 Oct 2026) | | Credit ratings | Moody's Baa2 (outlook negative, changed ~Aug 2026); S&P BBB (outlook negative since Aug 2025, affirmed Nov 2025); Fitch: BBB historically (current outlook n/v) | | CEO & Board Chair | Mark J. Costa (CEO since January 2014) | | Customers served | More than 100 countries | | Metric | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Employees (approx., headcount) | 14000 | 14000 | 13000 | Sources: FY2024 headcount from company boilerplate in August 2025 releases ("approximately 14,000"); FY2025/2026 from FY2025 results release and 2026 Proxy ("approximately 13,000"). The roughly 7% reduction between 2024 and 2025 aligns with corporate severance charges of USD 34 million booked in FY2025 (FY2025 financial tables, Table 3A note 7). Eastman is a ~USD 8.8 billion, Kingsport-headquartered specialty materials producer whose competitive identity rests on deeply integrated, largely U.S.-based asset complexes in Tennessee and Texas that convert coal-derived syngas, cellulose, propane and—increasingly—waste plastic into higher-value polymers, films, additives and fibers. Roughly two-thirds of revenue comes from two specialty segments (Advanced Materials and Additives & Functional Products) anchored by franchise brands such as Saflex interlayers, LLumar window films, Tritan copolyester, Therminol heat-transfer fluids and Naia textiles. The remaining third—Chemical Intermediates and Fibers—supplies scale, integration economics and cash but carries commodity cyclicality and structural decline risk (acetate tow). Management's differentiator is an "innovation-driven growth model" layered with a circular-economy platform (Kingsport methanolysis molecular recycling). The investment debate centres on whether innovation and circularity can outrun cyclical demand, an elevated 3x+ leverage profile, and a decade of flat-to-declining revenue. --- ### Company's own description (paraphrased from FY2025 releases and 2026 Proxy) Eastman describes itself as a global specialty materials company that produces a broad range of products found in everyday items, with a stated purpose of enhancing the quality of life in a material way. It attributes its growth to an innovation-driven model built on world-class technology platforms, deep customer engagement and differentiated application development, which it uses to grow leading positions in attractive end markets—explicitly naming transportation, building and construction, and consumables. The 2026 Proxy adds that its strategy is founded on innovating sustainable solutions and maintaining its social license to operate, framed around a "triple challenge" of carbon neutrality, circularity and caring for society. ### Independent characterization Eastman is best understood as a hybrid specialty/intermediates producer whose specialty franchises sit on top of integrated commodity-like streams. Four integrated technology streams underpin the portfolio: 1. **Acetyl/cellulosics stream (Kingsport):** coal gasification produces syngas → methanol → acetic acid/acetic anhydride; combined with wood pulp to make cellulose esters (cellulose acetate flake, CAB, CAP). Outputs feed acetate tow and textile yarn (Fibers), cellulose-ester coatings additives (AFP), and cellulose-based plastics (AM). 2. **Polyester/copolyester stream (Kingsport):** proprietary monomers (e.g., CHDM, TMCD) enable Tritan and Eastar copolyesters; the methanolysis molecular-recycling unit depolymerizes polyester waste back into monomers that substitute for virgin feedstock. 3. **Olefins/oxo stream (Longview, Texas — second-largest site):** propane/ethane cracking → propylene/ethylene → oxo alcohols, plasticizers, glycol ethers and solvents (Chemical Intermediates), plus feedstock for specialty additives. 4. **Alkylamines and specialty fluids (Taminco/Solutia heritage):** methylamines, ethylamines and higher amines for agriculture, water treatment, personal care and pharma; Therminol heat-transfer fluids and Skydrol aviation hydraulic fluids. ### Revenue model | Revenue type | Share of revenue | Comment | |---|---|---| | Product sales (B2B) | ~99%+ | Essentially all revenue is from manufactured-product sales under spot, contract and cost-pass-through arrangements | | Technology licensing | Not separately disclosed (immaterial) | Oxo process technology licensing; APAC licensing programs were discontinued in 4Q2025 (USD 13 million adjustment in CI segment) | | Services / subscription | None material | Technical service is bundled with product sales | Pricing mechanisms (FY2025 releases): AFP uses cost-pass-through contracts for a meaningful share of volume (price +3% in FY2025 explicitly attributed to them); Fibers acetate tow is sold under annual contracts with minimum commitments (2Q2026 call: tow volumes rise in 2H as customers meet annual minimums); CI is spread-driven against propane/ethylene and Asian competition; AM is value-priced (management "defended price" in 4Q2025 despite volume declines). ### Value-chain position Eastman sits in the mid-stream to downstream of the chemical value chain: it is backward-integrated into basic feedstocks (syngas, olefins) but sells primarily to converters and OEM tier suppliers—windshield laminators, film converters/installers, plastic molders, coatings formulators, agrochemical formulators, cigarette-filter makers and textile mills—rather than to consumers. Brand recognition at consumer level exists for a few franchises (LLumar films, Tritan in drinkware, Naia in apparel), which supports co-branding and pricing. ### Customer types and end markets The 2026 Proxy lists FY2025 revenue by end-use market across: Transportation; Building and Construction; Consumables; Durables and Electronics; Personal Care and Wellness; Filter Media; Medical and Pharma; Industrial Chemicals; Food, Feed and Agriculture; Water Treatment and Energy; and Other Markets. The proxy states 56% of revenue arises outside North America (FY2025). Customer concentration: no single customer is disclosed as ≥10% of sales in sources reviewed (n/v).
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
3 interactive charts drawn from the Monolaurin Feed Additive Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Monolaurin Feed Additive Market By Physical Form
Global Monolaurin Feed Additive Market By Livestock
Global Monolaurin Feed Additive Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
